IgD myeloma is an infrequent type of multiple myeloma and is characterized by an aggressive clinical behavior and a short survival time. No satisfactory treatments have thus far been established. Recently we treated a patient with IgD(lambda)-type myeloma with glucocorticoids, and succeeded in achieving a complete remission. This case seems to indicate a usefulness of glucocorticoid monotherapy for treating IgD myeloma.
作者：N, Takemori；K, Kondo；T, Kawamura；K, Imai；H, Sakurai；T, Sato
来源：American journal of hematology 2001 年 66卷 1期
